SCHEMBL20587712

SCHEMBL20587712

O=C(NN=Cc1cc(Br)cc(Br)c1O)c1ccc(OC(F)(F)F)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 1/20 0.57
MAPT P10636 10/20 0.52
MEN1 O00255 9/20 0.52
KMT2A Q03164 9/20 0.52
KDM4E B2RXH2 7/20 0.52
LMNA P02545 7/20 0.52
HTT P42858 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
NPC1 O15118 2/20 0.52
PKM P14618 1/20 0.52
SAE1 Q9UBE0 1/20 0.52
UBA2 Q9UBT2 1/20 0.52
MAPK1 P28482 2/20 0.49
SIRT1 Q96EB6 4/20 0.47
FTO Q9C0B1 1/20 0.47
TDP1 Q9NUW8 3/20 0.47
RAB9A P51151 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HPGD P15428 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20587710 1.00 PIK3CG (0.57) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL22179619 1.00 PIK3CG (0.57) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL20587328 0.87 PGR (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL22179636 0.87 PGR (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL20587330 0.87 PGR (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL684592 0.85 MAPT (0.65) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL20587714 0.84 PIK3CG (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL20587716 0.84 PIK3CG (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL22179546 0.84 PIK3CG (0.60) PIK3CGMAPTMEN1KMT2AKDM4E
SCHEMBL26974401 0.82 PIK3CG (0.79) PIK3CGMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-06-10 US disclosed
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-04-18 US disclosed
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-01-02 US disclosed
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-12-15 US disclosed
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-08-16 US disclosed
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-07-02 US disclosed
EP-3638649-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS The Research Foundation for The State University of New York (US) 2020-04-22 EP disclosed
WO-2018232298-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2018-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885MAPT 2146/4885MEN1 1341/4885
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, SMPD1 PIK3CG 383/4885MAPT 2073/4885MEN1 952/4885
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885MAPT 2146/4885MEN1 1341/4885
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, DPM1 PIK3CG 488/4885MAPT 2146/4885MEN1 1341/4885
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885MAPT 2146/4885MEN1 1341/4885
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, LSS PIK3CG 378/4885MAPT 1832/4885MEN1 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.